medigraphic.com

2005, Número S1

<< Anterior Siguiente >>

Rev Mex Anest 2005; 28 (S1)


Medicamentos antihipertensivos en el período peri-operatorio

González CO, Chávez-Tapia NC

Idioma: Español
Referencias bibliográficas: 35
Paginas: 154-156
Archivo PDF: 49.98 Kb.


FRAGMENTO

INTRODUCCIÓN

La hipertensión se ha reconocido desde el siglo pasado con los estudios de Ambard y Beaujard. Desde entonces y hasta inicios de 1990 la presión arterial fue clasificada en base a los niveles de presión arterial diastólica, reflejando el incremento en las resistencias vasculares periféricas. Sin embargo no es sino hasta 1980 con los resultados obtenidos del estudio Framingham donde se identifica que la hipertensión arterial sistólica aislada es un factor de riesgo importante para presentar enfermedad vascular cerebral, particularmente en adultos mayores con arterioloesclerosis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ambard L, Beaujard E. Causes de l’hypertension arterielle. Arch Gen Med 1904;1:520-533.

  2. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 1981;245:1225-9.

  3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.

  4. Swales JD, Textbook of hypertension. 1994, Oxford: Blackwell Scientific. xvi, 1328 , [6] of plates.

  5. Houston MC, Meador BP, Schipani LM, Handbook of antihypertensive therapy. 10th ed. 2000, Philadelphia: Hanley & Belfus. xv, 176.

  6. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.

  7. Prys-Roberts C, Foex P, Biro GP, Roberts JG. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 1973;45:671-81.

  8. Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979;50:285-92.

  9. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988;68:495-500.

  10. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, Miller D, Mangano DT. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88:7-17.

  11. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94.

  12. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, Whittemore AD. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999;88:477-82.

  13. Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995;75:793-5.

  14. Poelaert J, Roosens C. Perioperative use of dihydropyridine calcium channel blockers. Acta Anaesthesiol Scand 2000;44:528-35.

  15. Colson P, Saussine M, Seguin JR, Cuchet D, Chaptal PA, Roquefeuil B. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992;74:805-8.

  16. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, Viars P. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994;81:299-307.

  17. Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997;84:945-9.

  18. Eyraud D, Mouren S, Teugels K, Bertrand M, Coriat P. Treating anesthesia-induced hypotension by angiotensin II in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1998;86:259-63.

  19. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001;92:26-30.

  20. Eyraud D, Brabant S, Nathalie D, Fleron MH, Gilles G, Bertrand M, Coriat P. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 1999;88:980-4.

  21. Cullen PM, Turtle M, Prys-Roberts C, Way WL, Dye J. Effect of propofol anesthesia on baroreflex activity in humans. Anesth Analg 1987;66:1115-20.

  22. Reitan JA, Stengert KB, Wymore ML, Martucci RW. Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesth Analg 1978;57:31-6.

  23. Vuyk J, Mertens MJ, Olofsen E, Burm AG, Bovill JG. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology 1997;87:1549-62.

  24. Skues MA, Richards MJ, Jarvis AP, Prys-Roberts C. Preinduction atropine or glycopyrrolate and hemodynamic changes associated with induction and maintenance of anesthesia with propofol and alfentanil. Anesth Analg 1989;69:386-90.

  25. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O’Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985;71:202-10.

  26. Nichols WW, O’Rourke MF, Avolio AP, Yaginuma T, Murgo JP, Pepine CJ, Conti CR. Effects of age on ventricular-vascular coupling. Am J Cardiol 1985;55:1179-84.

  27. Franklin SS, Gustin Wt, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-15.

  28. Lievre M, Gueret P, Gayet C, Roudaut R, Haugh MC, Delair S, Boissel JP. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. Hypertension 1995;25:92-7.

  29. Harris P. Congestive cardiac failure: central role of the arterial blood pressure. Br Heart J 1987;58:190-203.

  30. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-64.

  31. Howell SJ, Hemming AE, Allman KG, Glover L, Sear JW, Foex P. Predictors of postoperative myocardial ischaemia. The role of intercurrent arterial hypertension and other cardiovascular risk factors. Anaesthesia 1997;52:107-11.

  32. Hull CJ. Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. Br J Anaesth 1986;58:1453-68.

  33. Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 2002;26:1037-42.

  34. James MF. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth 1989;62:616-23.

  35. Schroeder BM. Updated guidelines for perioperative cardiovascular evaluation for noncardiac surgery. American College of Cardiology. American Heart Association. Am Fam Physician 2002;66:1096, 1099-100, 1103-4 passim.




2020     |     www.medigraphic.com